Enoxaparin sodium and Uptravi drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Enoxaparin sodium (enoxaparin sodium) and Uptravi (selexipag). Common drug interactions include haemorrhagic stroke among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Enoxaparin sodium and Uptravi. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Enoxaparin sodium?

Enoxaparin sodium has active ingredients of enoxaparin sodium. It is often used in deep venous thrombosis. eHealthMe is studying from 24,181 Enoxaparin sodium users. Check the latest studies of Enoxaparin sodium.

What is Uptravi?

Uptravi has active ingredients of selexipag. eHealthMe is studying from 26,576 Uptravi users. Check the latest studies of Uptravi.

On Jul, 30, 2026

15 people who take Enoxaparin sodium and Uptravi together, and have interactions are studied.

Enoxaparin sodium and Uptravi drug interactions.

What are the common drug interactions of Enoxaparin Sodium and Uptravi, by gender? *:

female:

Haemorrhagic stroke (stroke caused by the rupture of a blood vessel in the brain)
Nasopharyngitis (inflammation of the nasopharynx)
Pericardial effusion (fluid around the heart)
Pericardial haemorrhage (bleeding into the heart)
Procedural complication
Pulse absent
Pupillary reflex impaired
Renal failure (kidney dysfunction)
Renal impairment (severely reduced kidney function)
Skin discolouration (change of skin colour)

male:

Dyspnoea (difficult or laboured respiration)
Fatigue (feeling of tiredness)
Dialysis related complication
Enterobacter test positive
Enterococcus test positive
General physical health deterioration (weak health status)
Genital erythema (redness of genitals)
Genital infection
Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood)
Hypokalaemia (low potassium)

What are the common drug interactions of Enoxaparin Sodium and Uptravi, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Haemorrhage intracranial (bleeding within the skull)
Haemorrhagic stroke (stroke caused by the rupture of a blood vessel in the brain)
Nasopharyngitis (inflammation of the nasopharynx)
Pericardial effusion (fluid around the heart)
Pericardial haemorrhage (bleeding into the heart)
Procedural complication
Pulse absent
Pupillary reflex impaired
Renal failure (kidney dysfunction)
Renal impairment (severely reduced kidney function)

30-39:

n/a

40-49:

Nausea (feeling of having an urge to vomit)
Headache (pain in head)
Cardiomegaly (increased size of heart than normal)
Cough
Dyspnoea (difficult or laboured respiration)
Electrolyte imbalance
Fall
Fatigue (feeling of tiredness)
Fluid overload (too much fluid in the blood)
Generalised oedema (swelling all over the body)

50-59:

Blood alkaline phosphatase increased
Blood creatine phosphokinase decreased
Blood urea decreased
Diarrhoea
Disease progression
Dyspnoea (difficult or laboured respiration)
Fatigue (feeling of tiredness)
Haematocrit decreased
N-terminal prohormone brain natriuretic peptide increased
Pulmonary arterial hypertension (high blood pressure in the arteries of lungs)

60+:

Dyspnoea (difficult or laboured respiration)
Fatigue (feeling of tiredness)
Dialysis related complication
Enterobacter test positive
Enterococcus test positive
General physical health deterioration (weak health status)
Genital erythema (redness of genitals)
Genital infection
Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood)
Hypokalaemia (low potassium)

What are the existing conditions these people have? *

Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 11 people, 73.33%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 6 people, 40.00%
Blood Magnesium Decreased: 3 people, 20.00%
Disease Progression: 3 people, 20.00%
Low Birth Weight Baby: 2 people, 13.33%
Hypotension (abnormally low blood pressure): 2 people, 13.33%
High Blood Pressure: 2 people, 13.33%
Urinary Tract Infection: 1 person, 6.67%
Enlarged Prostate: 1 person, 6.67%
Asthma: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Enoxaparin sodium and Uptravi?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously